Quote | Genenta Science S.p.A. (NASDAQ:GNTA)
Last: | $4.51 |
---|---|
Change Percent: | -3.04% |
Open: | $4.74 |
Close: | $4.51 |
High: | $4.75 |
Low: | $4.1381 |
Volume: | 37,311 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Genenta Science S.p.A. (NASDAQ:GNTA)
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
2024-05-28 06:10:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the oldest maxims in investing is that higher risk produces greater returns. That maxim holds particularly true across penny biotech stocks. Developing therapeutics to cure diseases ...
Message Board Posts | Genenta Science S.p.A. (NASDAQ:GNTA)
Subject | By | Source | When |
---|---|---|---|
FDAs decision to grant Orphan Drug Designation to | Luckypennyman | investorshub | 03/02/2023 3:17:27 PM |
$GNTA: Just got a $15 PriceTarget upgrade. | makinezmoney | investorshub | 01/05/2023 2:59:42 PM |
Maxim starts Genenta Science at buy; PT $21 | conix | investorshub | 01/18/2022 8:55:03 PM |
is this genta that we have before, it | asser_al7ob | investorshub | 01/15/2022 4:41:36 AM |
Clinical-stage biotechnology company pioneering | Phosphene | investorshub | 12/28/2021 7:57:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Genenta Science S.p.A. Company Name:
GNTA Stock Symbol:
NASDAQ Market:
Genenta Science S.p.A. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors, announces that ...